I still believe that INO will follow a similar path as ACAD, which was as low as $1.80 last November and is quickly approaching $30. ONCS uses same technology as INO and is a bargain at 27 cents.
For INO investors, this date marks the beginning of the transformation and validated Inovio' s technology in the healthcare industry. More partnerships to be announced soon as big pharma and the biotech world see the value. It's obvious that the pps is being manipulated to allow for cheaper shares. The bashers and shorts will be relentless...they don't have much time left. Dr. Kim and his management team could not have played the timing of the announcement any better. Congratulations to those who believed in INO. It's "just the beginning"
as Dr. Kim stated this morning.
The Inovio-Roche partnership proves that big pharmaceutical believes in electtoporation. ONCS will ride this technology and benefit from INO' s run. Let the great rotation begin!
Just needs to finish in the positive...if it does, a great sign. Today was profit taking day...going to happen as INO continues its run.
And that's why this is reasonably priced at 35 cents. The presentation did not have any impact on trading...low expectations overall by investors. If volume remains high. A possible move to 40 cents...but looking for much lighter volume tomorrow.
Breakout imminent...today, tomorrow, this week. It is coming as the volume continues to surge. Following the INO path. It's the technology that provides the payoff. Under major accumulation right now.